Last deal

$2.15M
Local Amount - EUR 2.3M

Amount

Seed

Stage

07.11.2023

Date

3

all rounds

$2.42M

Total amount

date founded

Financing round

General

About Company
VALANX Biotech provides a site-specific protein conjugation platform for fast and cost-efficient protein-drug-conjugates development.

Industry

Sector :

Subsector :

Keywords :

founded date

23.03.2017

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company develops a proprietary technology that solves the problem of tedious and ineffective protein conjugation, allowing healthcare providers to produce receptor proteins with site-specific chemical handles attached. This platform has applications in therapeutics, diagnostics, and biocatalysis, and enables the development of drugs that target only cancer cells.
Contacts

Social url

Similar Companies
1000
Abilita Bio

Abilita Bio

Abilita Bio is a biotechnology company that develops drugs targeting membrane proteins.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Diego, CA, USA

total rounds

1

total raised

$7.5M
BrickBio

BrickBio

BrickBio is a bioconjugation platform that optimizes protein modification for research purposes.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

Boston, MA, USA

total rounds

2

total raised

$5M
Invitris

Invitris

Invitris is a biotech firm specializing in the creation of protein-based medications.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Manufacturing

Location

85748 Garching, Germany

total rounds

1

total raised

$500K
Biointron

Biointron

Biointron is a leading provider of high-quality and cost-effective recombinant protein/antibody reagents.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

Shanghai, China

total rounds

2

total raised

$72.46M

Financials

Funding Rounds
9
3

Number of Funding Rounds

$2.42M

Money Raised

Their latest funding was raised on 07.11.2023. Their latest investor SOSV. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
07.11.2023
4
$2.15M
Local Amount - EUR 2.3M
23.06.2023
1
21.12.2021
1

SkyGene

SkyGene is a biotech-focused venture capital firm.

Sector

General Industrials

Subsector

Diversified Industrials

count Of Investments

1
Co-Investors
Investors
6
4

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Seed
Yes
Seed
SOSV

SOSV

SOSV is a global venture capital firm that supports early-stage startups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital

Location

Princeton, NJ, USA

count Of Investments

2641

count Of Exists

91
IST cube

IST cube

ITS Cube is a venture capital firm that invests in deep tech startups and academic spin-offs.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Klosterneuburg, Austria

count Of Investments

25

Alexander Schwartz

Dr. Alexander Schwartz serves as a Managing Partner at IST Cube. He also serves as a Board Member at Valanx Biotech, Ribbon Biolabs, and VitreaLab. He serves as an Advisory Board Member at West Asia Investment Partners. He is a managing partner and strategy advisor at ARACON Consulting, and has over 15 years of strategy consulting experience, leading projects in Europe, the United States, and the Middle East. Previously, he worked at the Strategy Practice, Chemicals Practice, and Climate Change practice at McKinsey & Company for eight years. He has been the president of the Harvard Club of Austria since 2013. He holds a PhD in Organic Chemistry from the University of Vienna and was a postdoctoral fellow at Harvard University, as well as a visiting researcher at ETH Zurich. He is currently a research scholar at the International Institute for Applied Systems Analysis (IIASA).

current job

IST cube
IST cube

SkyGene

SkyGene is a biotech-focused venture capital firm.

Sector

General Industrials

Subsector

Diversified Industrials

count Of Investments

1

People

Founders
2
Patrik Fladischer
Patrik Fladischer

Patrik Fladischer

Patrik has worked with their technology now for more than four years and will soon be a PhD in biotechnology. He knows the ins and outs of biotechnology and has a knack to come up with out-of-the-box innovative solutions to scientific problems. As a volunteer at the Austrian Red Cross Patrik has additional training in communication, team building and leadership. He likes hiking, soccer and exploring new things.

current job

VALANX Biotech
VALANX Biotech

organization founded

1

Patrik Fladischer

Michael Lukesch
Michael Lukesch

Michael Lukesch

Michael studied Chemistry, followed by a PhD in Biotechnology. He is a motivated, optimistic self-starter person and likes to innovate and bring new ideas and concepts to reality. Through various activities he aquired education and experience in project management, communications, team leadership and business. He likes to spend his free time in nature, exploring and meeting new people.

current job

VALANX Biotech
VALANX Biotech

organization founded

1

Michael Lukesch

Employee Profiles
2
Michael Lukesch

Michael Lukesch

CEO & Co-Founder

Patrik Fladischer

Patrik Fladischer

CSO & Co-Founder

Activity

Recent News
2